Resources Contact Us Home
Oligoadenylate synthetase (OAS)

Image Number 2 for United States Patent #8133710.

The invention describes novel pharmaceutical compositions for the treatment of virus infections and cancer. The pharmaceutical compositions include mutant oligoadenylate synthetases (OAS) that have either enhanced cell permeability, reduced oxidative potential, improved antiviral activity, improved enzymatic activity, or absent enzymatic activity. The pharmaceutical compositions have improved drug properties and retain or have enhanced antiviral activity relative to their native forms. The pharmaceutical compositions further include chemically modified oligoadenylate synthetases, such chemical modifications being designed to increase serum stability and reduce immunogenicity in vivo. Such chemical modifications further increase drug stability and manufacturability in vitro. Compositions composed of more than ninety novel modifications are described. Also described are antibodies to polypeptides of the invention.

  Recently Added Patents
Error scanning in flash memory
Polynucleotide capture materials, and methods of using same
5-lipoxygenase-activating protein (FLAP) inhibitors
Cable preparation tool
Use of physical deformation during scanning of an object to generate views of the object
Method of preparing highly fluorinated carboxylic acids and their salts
Sweetener compositions having enhanced sweetness and improved temporal and/or flavor profiles
  Randomly Featured Patents
Organic stripping compositions and method for using same
Holder for a credit or transaction card
Analysis of optic nerve head shape
User interface for a portion of a display screen
Anchoring system for injection molded magnets on a flux ring or motor housing
Polymere N-halogenamide auf basis von acryl-und methacrylamid
Contacting identity sharing
Gaming system and method for adjusting the average expected payback associated with a play of a wagering game
RJ-45 socket
Electrical connection device